Picture of Principal Technologies logo

PTEC Principal Technologies Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+8.89%
3m-6.43%
6m+9.98%
1yr+28.46%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-156.12%
Return on Equity-331.68%
Operating Margin-253.05%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202431st Jul 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Principal Technologies EPS forecast chart

Profile Summary

Principal Technologies Inc. is a Canada-based company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. It operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The Company's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.

Directors

    Last Annual
    July 31st, 2023
    Last Interim
    January 31st, 2024
    Incorporated
    April 3rd, 2018
    Public Since
    November 1st, 2018
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    ca flag iconTSX Venture Exchange
    Shares in Issue
    32,868,627

    PTEC Share Price Performance

    Upcoming Events for PTEC

    Similar to PTEC

    Picture of Arch Biopartners logo

    Arch Biopartners

    ca flag iconTSX Venture Exchange

    Picture of biOasis Technologies logo

    biOasis Technologies

    ca flag iconTSX Venture Exchange

    Picture of Ceapro logo

    Ceapro

    ca flag iconTSX Venture Exchange

    Picture of Covalon Technologies logo

    Covalon Technologies

    ca flag iconTSX Venture Exchange

    Picture of Hemostemix logo

    Hemostemix

    ca flag iconTSX Venture Exchange

    FAQ